Blood Collection Tubes Market Size, Share, Opportunities, And Trends By Product Type (EDTA Tubes, Heparin Tube, Heparin Plasma Separating Tube, Serum Separating Tube, Others), By Material Type (Plastic (Polyethylene Terephthalate, Polypropylene, Polystyrene, Others), Glass), By End-User (Diagnostic Centers, Hospitals and Clinics, R&D Centers,) And By Geography - Forecasts From 2023 To 2028

The blood collection tubes market is projected to witness a compound annual growth rate of 6.45% to grow to US$2.859 billion by 2028 from US$1.847 billion in 2021.

The blood collection tubes market is anticipated to grow significantly in the projected period due to multiple reasons such as the increasing geriatric population and the increasing incidence of chronic diseases. Diseases such as tuberculosis are increasing around the world. For instance, as per the World Health Organization (WHO) the number of people suffering from tuberculosis (TB) was an estimated 10.2 million of which 1.2 million were children, such increasing prevalence is providing an edge for market growth. Furthermore, the market is driven by increasing blood collection in various countries. For instance, according to the WHO’s June 2023 article 118.5 million blood donations were collected globally of which 40% of these were collected in high-income countries that are home to 16% of the world’s population. Increasing surgeries and increasing blood donation are increasing the market demand for blood collection tubes market.

Increasing Surgeries and Chronic Diseases All Around The World

Chronic diseases such as diabetes are increasing all around the world with the increased prevalence of diseases there is an increasing need to treat the patient and get the person’s blood reports. Such increasing burden on collection of blood and storing them correctly is increasing the demand for increasing blood collection tubes in the projected period. For instance, according to a press release by the Canadian government in August 2021, almost 3 million, or 8.8% of the total population was suffering from diabetes, and 6.1% of the population was at high risk for developing diabetes. Hence, such an increase in chronic diseases is pushing the market in an upward direction.

According to the International Diabetes Federation (IDF), in 2021 537 million people were suffering from diabetes, the IDF estimates that by 2030 this figure will reach 643 million, and in 2045 every 1 in 8 people will suffer from diabetes making a total of 783 million people. The increase in such diseases is propelling the market growth.

Additionally, the increasing number of surgical procedures is also one of the reasons for market growth. For instance, the Organization for Economic Co-operation and Development in August 2022, released the stats that surgeries performed in European Union in countries such as Portugal, Denmark, Norway, and Ireland include 94.87, 49.33, 21.5, and 32.84 in thousands. Such increasing surgical procedures where the blood needs to be collected and kept for testing and other procedures are propelling the market growth for blood collection tubes in the projected period.

The United States in North America is an Expected Dominant Market

The US healthcare industry is the largest in the world, with total spending of over $3.8 trillion in 2022. This large and growing market provides a significant opportunity for microfluidics companies. POC diagnostics are medical tests that can be performed outside of a traditional laboratory setting, such as in a doctor's office or at home. Microfluidics is a key technology in POC diagnostics, as it allows for the miniaturization of these tests, making them more portable, affordable, and accessible.

Moreover, the rising number of surgeries is also another major factor driving the growth of the blood collection tubes market. Blood collection tubes are essential for blood collection during surgeries, which is driving the demand for these tubes. For instance, in January 2023, BD launched its BD Vacutainer® Serum Tube with K2EDTA, a new blood collection tube for serum separation which is useful for surgical purposes. Further driving this momentum is the increasing technological advancements in the blood collection tubes market in recent years. These advancements have led to the development of new and innovative blood collection tubes that are more efficient and user-friendly.

The escalating number of new cancer cases in the USA from 2020 to 2022 underscores the persistent challenge of chronic illnesses, particularly among the aging population. As cancer diagnoses surge, there's an increasing demand for routine blood tests, critical for diagnosis and treatment monitoring. Blood collection tubes are pivotal in facilitating sample collection for a plethora of tests, playing an integral role in the early detection and management of diseases, aligning with the surge in chronic conditions and heightened medical testing demands driven by the aging demographic. This symbiotic relationship fuels the growth of the Blood Collection Tubes Market in the USA.

Key Developments

• In August 2022, SeptiCyte RAPID EDTA blood-compatible cartridges were released by Immunexpress, Pty Ltd for the European market. Haematology operations in clinical settings use EDTA blood collection tubes.
• In April 2023, Terumo launched its Terumo® Blood Collection Tubes with Lithium Heparin, a new line of blood collection tubes that are designed for coagulation testing.

Blood Collection Tubes Market Scope:

 

Report Metric	Details
Market Size Value in 2021	US$1.847 billion
Market Size Value in 2028	US$2.859 billion
Growth Rate	CAGR of 6.45% from 2021 to 2028
Base Year	2021
Forecast Period	2023–2028
Forecast Unit (Value)	USD Billion
Segments Covered	Product Type, Material Type, End-User, And Geography
Regions Covered	North America, South America, Europe, Middle East and Africa, Asia Pacific
Companies Covered	BD, Cardinal Health, CHENGDU RICH SCIENCE INDUSTRY CO., LTD., FL MEDICAL S.r.l., Fresenius Kabi AG, Greiner Bio One International GmbH, Thermo Fisher Scientific Inc., Kawasumi Laboratories America, McKesson Medical-Surgical Inc., QIAGEN, SARSTEDT AG & Co. KG, AdvaCare Pharma
Customization Scope	Free report customization with purchase

 

Segmentation:

• By Product Type
  • EDTA Tubes
  • Heparin Tube
  • Heparin Plasma Separating Tube
  • Serum Separating Tube
  • Others
• By Material Type
  • Plastic
    • Polyethylene Terephthalate
    • Polypropylene
    • Polystyrene
    • Others
  • Glass
• By End-User
  • Diagnostics Centers
  • Hospitals and Clinics
  • R&D Centers
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • United Kingdom
    • Germany
    • France
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Indonesia
    • Thailand
    • Others

---

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY  

2.1. Research Design

2.2. Research Data

2.3. Validation

3. EXECUTIVE SUMMARY

3.1. Key Findings

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Forces Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

5. BLOOD COLLECTION TUBES MARKET ANALYSIS, BY PRODUCT TYPE 

5.1. Introduction

5.2. EDTA Tubes

5.3. Heparin Tube

5.4. Heparin Plasma Separating Tube

5.5. Serum Separating Tube

5.6. Others

6. BLOOD COLLECTION TUBES MARKET ANALYSIS, BY MATERIAL TYPE 

6.1. Introduction

6.2. Plastic

6.2.1. Polyethylene Terephthalate

6.2.2. Polypropylene

6.2.3. Polystyrene

6.2.4. Others

6.3. Glass

7. BLOOD COLLECTION TUBES MARKET ANALYSIS, BY END-USER

7.1. Introduction 

7.2. Diagnostics Centers

7.3. Hospitals and Clinics

7.4. R&D Centers

8. BLOOD COLLECTION TUBES MARKET ANALYSIS, BY GEOGRAPHY 

8.1. Introduction

8.2. North America

8.2.1. By Product Type

8.2.2. By Material Type

8.2.3. By End-Users

8.2.4. By Country

8.2.4.1. United States

8.2.4.2. Canada

8.2.4.3. Mexico

8.3. South America

8.3.1. By Product Type

8.3.2. By Material Type

8.3.3. By End-Users

8.3.4. By Country

8.3.4.1. Brazil

8.3.4.2. Argentina

8.3.4.3. Others

8.4. Europe

8.4.1. By Product Type

8.4.2. By Material Type 

8.4.3. By End-Users

8.4.4. By Country

8.4.4.1. UK

8.4.4.2. Germany

8.4.4.3. France

8.4.4.4. Spain

8.4.4.5. Others

8.5. Middle East and Africa

8.5.1. By Product Type

8.5.2. By Material Type

8.5.3. By End-Users

8.5.4. By Country

8.5.4.1. Saudi Arabia

8.5.4.2. United Arab Emirates

8.5.4.3. Israel

8.5.4.4. Others

8.6. Asia Pacific

8.6.1. By Product Type

8.6.2. By Material Type

8.6.3. By End-Users

8.6.4. By Country

8.6.4.1. Japan

8.6.4.2. China

8.6.4.3. India

8.6.4.4. South Korea

8.6.4.5. Indonesia

8.6.4.6. Taiwan

8.6.4.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Emerging Players and Market Lucrativeness

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Vendor Competitiveness Matrix

10. COMPANY PROFILES

10.1. BD

10.2. Cardinal Health

10.3. CHENGDU RICH SCIENCE INDUSTRY CO., LTD.

10.4. FL MEDICAL S.r.l.

10.5. Fresenius Kabi AG

10.6. Greiner Bio One International GmbH

10.7. Thermo Fisher Scientific Inc.

10.8. Kawasumi Laboratories America

10.9. McKesson Medical-Surgical Inc.

10.10. QIAGEN

10.11. SARSTEDT AG & Co. KG

10.12. AdvaCare Pharma

BD

Cardinal Health

CHENGDU RICH SCIENCE INDUSTRY CO., LTD.

FL MEDICAL S.r.l.

Fresenius Kabi AG

Greiner Bio One International GmbH

Thermo Fisher Scientific Inc.

Kawasumi Laboratories America

McKesson Medical-Surgical Inc.

QIAGEN

SARSTEDT AG & Co. KG

AdvaCare Pharma